Inhibrx Biosciences, Inc.(INBX)Earnings Date, History & Expected Move

Next report
Nov 13, 2026

INBX is scheduled to report on Nov 13, 2026, usually after the market closes. Analysts expect EPS of -$2.57.

Next report
Nov 13, 2026
In 20 days · usually after close
EPS beat rate
43%
3 of 7 quarters (+1 not counted)
Avg move after earnings
±6.1%
Up 43% of the time · last 7
Options-implied move
—
No reliable options quote yet

EPS: Actual vs Estimate

Reported EPS against the consensus estimate, last 8 quarters.

Green beat or met, red missed, amber sources differ.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±6.1%).

Did the stock rise after good news?

The next-day move after each of its last 2 EPS beats and 4 misses.

When it beat expectations
2 reports
When it missed expectations
4 reports
Report by report
  • May '26
    Missed
    ▼ -6.5%
  • Mar '26
    Missed
    ▼ -6.1%
  • Nov '25
    Missed
    ▲ +6.0%
  • May '25
    Beat
    ▲ +10.9%
  • Mar '25
    Missed
    ▲ +0.4%
  • Nov '24
    Beat
    ▼ -3.5%

Clear beats and misses with a known reaction only. What counts as a beat

After an EPS beat
+3.7%
average next-day move · up 50% of 2 times
After an EPS miss
-1.5%
average next-day move · up 50% of 4 times

Why did INBX fall after beating earnings?

3 of INBX's last 6 reactions went against the EPS result. What stands out in each:

INBX beat EPS estimates in 2 quarters, and the stock still closed lower the next day 1 time.

  • Nov 14, 2024EPS beat +23.2%stock -3.5% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

Rose despite an EPS miss (2 of 4)

  • Nov 14, 2025EPS missed -32.6%stock +6.0% next day
    • It had already fallen 7.9% in the final week before the report, so weak results may have been expected.
  • Mar 17, 2025EPS missed -55.2%stock +0.4% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

Patterns in estimates and prices, not confirmed causes: how we read them.

Was INBX's earnings move already priced in?

INBX's move in the month before each of its last 7 reports, against what it did after.

Avg move in the month before
+16.8%
last 7 reports
Higher before the report
57%
of the time
After a run-up of 3%+
Fell 50%
4 reports, avg -2.2%
After a drop of 3%+
Rose 33%
3 reports, avg +0.4%

How the run-up is measured (a move of 5% or more counts as large).

Before vs after each report

Grey: the month before each of the last 7 reports. Green or red: the day after.

Past reports only. How the run-up is measured

Does INBX hold its opening gap after earnings?

INBX's opening move after each report and where it closed that day.

In 6 reports INBX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 6 times (50%), and fully reversed 3 times. Gaps up faded 1 of 2; gaps down recovered 2 of 4.

  • Aug 13, 2026Held
    Opened -5.4%, closed -8.9%
  • May 14, 2026Reversed
    Opened +2.1%, closed -6.5%
  • Mar 19, 2026Held
    Opened -1.5%, closed -6.1%
  • Nov 14, 2025Reversed
    Opened -2.3%, closed +6.0%
  • May 14, 2025Held
    Opened +1.2%, closed +10.9%
  • Mar 17, 2025Reversed
    Opened -2.9%, closed +0.4%

How gaps, fades and reversals are defined

What the history says

  • INBX has missed EPS estimates in 3 straight quarters (quarters where our data sources disagree are skipped).

INBX earnings history

Last 8 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report dateTimeEPS est.EPS actualSurprise1-day move3-day move
Aug 13, 2026After close-$2.28-$2.34sources differ-8.91%-2.46%
May 14, 2026After close-$1.20-$2.15-79.2%-6.47%-5.72%
Mar 19, 2026After close-$2.08-$2.11-1.4%-6.09%-2.70%
Nov 14, 2025Before open-$1.72-$2.28-32.6%+6.04%+3.98%
Aug 13, 2025After close-$2.76-$1.85+33.0%——
May 14, 2025After close-$3.12-$2.80+10.3%+10.89%+15.04%
Mar 17, 2025After close-$2.88-$4.47-55.2%+0.43%+1.15%
Nov 14, 2024After close-$3.70-$2.84+23.2%-3.49%-0.28%

Consensus for the next report: EPS -$2.57, revenue $0.00.

INBX Earnings FAQ

Answers computed from Inhibrx Biosciences, Inc.'s reported history

INBX is scheduled to report on Nov 13, 2026, usually after the market closes. Analysts expect EPS of -$2.57.

Over the last 7 quarters with a usable EPS surprise, INBX beat the consensus estimate 3 times (43%), missed 4 and landed in line 0. It has missed estimates in each of the last 3 counted quarters. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.

Across its last 7 quarters with a measured reaction, INBX moved an average of ±6.1% in the first session after reporting. It closed higher 43% of the time; the largest gain was 10.9% and the largest drop -8.9%.

Across its last 7 quarters with price data, INBX moved an average of +16.8% in the 20 trading sessions before reporting and was higher in 57% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging -2.2%. After a drop of 3% or more (3 quarters), it rose the next day 33% of the time, averaging +0.4%. This describes past reports; it is not a forecast.

In 6 reports INBX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 6 times (50%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.

How we calculate these numbers · INBX: 8 reported quarters, latest Aug 13, 2026. Information only, not investment advice.

Looking for more on INBX?

Price charts, forecast, fundamentals and risk pages for INBX are not on Tickzen yet. You can run a full stock analysis now.

Run the INBX Stock Analyzer